Found: 1
Select item for more details and to access through your institution.
Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 177, doi. 10.1177/13524585231216854
- By:
- Publication type:
- Article